United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 274,900 | 1,334,700 | 970,400 | 631,700 | 322,200 |
| Depreciation Amortization | 22,600 | 85,600 | 62,800 | 40,900 | 19,800 |
| Income taxes - deferred | 25,900 | 97,700 | N/A | N/A | 0 |
| Accounts receivable | 38,200 | -70,900 | -18,400 | -100,000 | -42,700 |
| Accounts payable and accrued liabilities | -12,700 | 97,900 | 74,700 | 43,500 | -2,600 |
| Other Working Capital | 12,400 | -106,500 | 37,500 | -125,000 | 78,000 |
| Other Operating Activity | 102,000 | 122,700 | 88,000 | 161,800 | 86,500 |
| Operating Cash Flow | $463,300 | $1,561,200 | $1,215,000 | $652,900 | $461,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 581,200 | -1,598,800 | -1,053,500 | -1,233,600 | -692,300 |
| PPE Investments | -100,800 | -520,500 | -347,600 | -137,100 | -74,900 |
| Purchase Of Investment | -5,700 | -10,400 | -15,500 | -9,800 | -9,200 |
| Sale Of Investment | 269,000 | 1,583,900 | 1,098,400 | 915,900 | 611,700 |
| Purchase Sale Intangibles | N/A | -5,500 | -5,500 | N/A | N/A |
| Other Investing Activity | 0 | -5,500 | -5,500 | 0 | 0 |
| Investing Cash Flow | $743,700 | $-551,300 | $-323,700 | $-464,600 | $-164,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 200,000 | 200,000 | 200,000 | N/A |
| Common Stock Issued | 73,900 | 183,100 | 84,100 | 39,600 | 21,500 |
| Common Stock Repurchased | -1,558,300 | -1,016,600 | -1,016,000 | -15,500 | -15,300 |
| Other Financing Activity | 0 | -516,500 | -516,500 | -516,500 | -100,000 |
| Financing Cash Flow | $-1,484,400 | $-1,150,000 | $-1,248,400 | $-292,400 | $-93,800 |
| Beginning Cash Position | 1,557,100 | 1,697,200 | 1,697,200 | 1,697,200 | 1,697,200 |
| End Cash Position | 1,279,700 | 1,557,100 | 1,340,100 | 1,593,100 | 1,899,900 |
| Net Cash Flow | $-277,400 | $-140,100 | $-357,100 | $-104,100 | $202,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 463,300 | 1,561,200 | 1,215,000 | 652,900 | 461,200 |
| Capital Expenditure | -100,800 | -520,500 | -347,600 | -137,100 | -74,900 |
| Free Cash Flow | 362,500 | 1,040,700 | 867,400 | 515,800 | 386,300 |